急诊低敏肌钙蛋白T患者长期预后与普通人群比较
瑞典七家急诊胸痛且至少一次hs-cTnT检测患者纳入研究,排除心肌损伤者。可检测到hs-cTnT(5-14 ng/L)相比不可检测(<5 ng/L)与长期MACE风险增加相关,而不可检测者死亡风险低于普通人群但未来MI风险略高。
要点
- 急诊胸痛且hs-cTnT<5 ng/L者全因死亡风险低于普通人群,但未来MI诊断风险略高。
- hs-cTnT 5-14 ng/L者相比<5 ng/L者,首次MACE调整风险增加1.6倍。
- 低水平hs-cTnT的预后意义与年龄相关,≥65岁患者死亡风险均较低。
核心结论
- 急诊胸痛且hs-cTnT不可检测者总体死亡风险低于普通人群,风险高度依赖年龄。
- 可检测到的低水平hs-cTnT仍与长期心血管风险增加相关。
研究设计与样本
- 排除心肌损伤(任何hs-cTnT>14 ng/L)包括心肌梗死患者。
- 计算标准化死亡比(SMR)和标准化发病比(SIR),比较观察事件与普通人群预期事件。
主要发现
- 峰值hs-cTnT<5 ng/L者全因死亡SMR为0.83(95%CI 0.79-0.87),低于普通瑞典人群。
- 峰值hs-cTnT<5 ng/L者未来心肌梗死诊断SIR为1.39(95%CI 1.32-1.47)。
- 低水平(5-14 ng/L)对比不可检测(<5 ng/L)的首次MACE调整HR为1.61(95%CI 1.53-1.70)。
临床怎么用
- 急诊胸痛患者hs-cTnT<5 ng/L提示总体死亡风险较低,但需关注未来心肌梗死风险。
- hs-cTnT 5-14 ng/L者长期心血管风险增加,可能需要更密切随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Long-term prognosis associated with low-high-sensitivity cardiac troponin T (hs-cTnT) concentrations in patients with chest pain is unknown. We investigated these prognostic implications compared with the general population. METHODS: All first visits to seven emergency departments (ED)s in Sweden were included from 9 December 2010 to 31 August, 2017 by patients presenting with chest pain and at least one hs-cTnT measured. Patients with myocardial injury (any hs-cTnT >14 ng/L), including patients with myocardial infarction (MI) were excluded. Standardised mortality ratios (SMRs) and standardised incidence ratios (SIRs) were calculated as the ratio of the number of observed to expected events. The expected number was computed by multiplying the 1-year calendar period-specific, age-specific and sex-specific follow-up time in the cohort with the corresponding incidence in the general population. HRs were calculated for all-cause mortality and major adverse cardiovascular events (MACE), defined as acute MI, heart failure hospitalisation, cerebrovascular stroke or cardiovascular death, between patients with undetectable (<5 ng/L) and low (5-14 ng/L) hs-cTnT. RESULTS: A total of 1 11 916 patients were included, of whom 69 090 (62%) and 42 826 (38%) had peak hs-cTnT concentrations of <5 and 5-14 ng/L. Patients with undetectable peak hs-cTnT had a lower mortality risk compared with the general Swedish population (SMR 0.83, 95% CI 0.79 to 0.87), with lower risks observed in all patients ≥65 years of age, but a slightly higher risk of being diagnosed with a future MI (SIR 1.39, 95% CI 1.32 to 1.47). The adjusted risk of a first MACE associated with low versus undetectable peak hs-cTnT was 1.6-fold (HR 1.61, 95% CI 1.53 to 1.70). CONCLUSION: Patients with chest pain and undetectable hs-cTnT have an overall lower risk of death compared with the general population, with risks being highly age dependent. Detectable hs-cTnT concentrations are still associated with increased long-term cardiovascular risks.
引用
- Cyon, Kadesjö, Edgren, et al. Long-term prognosis of low high-sensitivity cardiac troponin T in the emergency department compared with the general population. Heart. 2024. PMID: 38849151. doi:10.1136/heartjnl-2024-323913
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。